SCHEMBL4619595

SCHEMBL4619595

Cc1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NCCN1CCOCC1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
MAPK1 P28482 2/20 0.67
CYP3A4 P08684 2/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C19 P33261 1/20 0.58
TSHR P16473 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
USP2 O75604 1/20 0.53
PKM P14618 2/20 0.53
HPGD P15428 2/20 0.52
HSD17B10 Q99714 1/20 0.52
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
CYP2C9 P11712 1/20 0.50
KMT2A Q03164 1/20 0.50
POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636995 0.94 CYP3A4 (0.67) ALDH1A1MAPK1CYP3A4CYP2D6CYP2C19
SCHEMBL4618904 0.90 ALDH1A1 (0.68) ALDH1A1MAPK1CYP3A4CYP2D6CYP2C19
SCHEMBL6102033 0.90 SIGMAR1 (0.54) ALDH1A1MAPK1CYP3A4CYP2D6CYP2C19
SCHEMBL4618056 0.89 ALDH1A1 (0.67) ALDH1A1MAPK1CYP3A4CYP2D6CYP2C19
SCHEMBL4617223 0.85 SFRP1 (0.64) ALDH1A1CYP3A4CYP2D6CYP2C19L3MBTL1
SCHEMBL4638749 0.84 SFRP1 (0.66) ALDH1A1MAPK1CYP3A4CYP2D6CYP2C19
SCHEMBL4617959 0.83 SFRP1 (0.56) CYP3A4CYP2D6CYP2C19L3MBTL1KMT2A
SCHEMBL4617527 0.81 SFRP1 (0.49) ALDH1A1MAPK1CYP3A4CYP2D6CYP2C19
SCHEMBL4616478 0.80 SFRP1 (0.66) ALDH1A1MAPK1TSHRL3MBTL1MEN1
SCHEMBL4616479 0.79 SFRP1 (0.74) ALDH1A1MAPK1TSHRL3MBTL1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 ALDH1A1 1865/4885MAPK1 934/4885CYP3A4 3233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.